Compile Data Set for Download or QSAR
maximum 50k data
Found 125 Enz. Inhib. hit(s) with all data for entry = 10939
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580009(US11485736, Compound Table 2.18)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580010(US11485736, Compound Table 2.19)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580011(US11485736, Compound Table 2.20)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580012(US11485736, Compound Table 2.21)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580013(US11485736, Compound Table 2.22)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580014(US11485736, Compound Table 2.23)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580087(US11485736, Compound TABLE 4.5)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580016(US11485736, Compound Table 2.25)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580017(US11485736, Compound Table 3.1)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580018(US11485736, Compound Table 3.2)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580019(US11485736, Compound Table 3.3)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580020(US11485736, Compound Table 3.4)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580021(US11485736, Compound Table 3.5)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580015(US11485736, Compound Table 2.24)
Affinity DataIC50: <10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM579996(US11485736, Compound Table 2.5)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM579997(US11485736, Compound Table 2.6)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM579998(US11485736, Compound Table 2.7)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM579999(US11485736, Compound Table 2.8)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580000(US11485736, Compound Table 2.9)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580001(US11485736, Compound Table 2.10)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580002(US11485736, Compound Table 2.11)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580003(US11485736, Compound Table 2.12)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580004(US11485736, Compound Table 2.13)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580005(US11485736, Compound TABLE 4.34 | US11485736, Comp...)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580006(US11485736, Compound Table 2.15 | US11485736, Comp...)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580007(US11485736, Compound Table 2.16)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580008(US11485736, Compound Table 2.17)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580022(US11485736, Compound Table 3.6)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580023(US11485736, Compound Table 3.7)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580024(US11485736, Compound Table 3.14 | US11485736, Comp...)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580025(US11485736, Compound Table 3.9)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580026(US11485736, Compound Table 3.10)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580027(US11485736, Compound Table 3.11)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580028(US11485736, Compound Table 3.12)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580029(US11485736, Compound Table 3.13)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580024(US11485736, Compound Table 3.14 | US11485736, Comp...)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580031(US11485736, Compound Table 3.15)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580032(US11485736, Compound Table 3.16)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580033(US11485736, Compound Table 3.17)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580034(US11485736, Compound Table 3.18)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580035(US11485736, Compound Table 3.19)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580036(US11485736, Compound Table 3.20)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580037(US11485736, Compound Table 3.21)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580038(US11485736, Compound Table 3.22)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580006(US11485736, Compound Table 2.15 | US11485736, Comp...)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580040(US11485736, Compound Table 3.24)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580041(US11485736, Compound Table 3.25)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580042(US11485736, Compound Table 3.26)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580043(US11485736, Compound Table 3.27)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
Ksq Therapeutics

US Patent
LigandPNGBDBM580044(US11485736, Compound Table 3.28)
Affinity DataIC50:  55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 125 total ) | Next | Last >>
Jump to: